Loading...
Adjuvant Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer
Nonrandomized studies have suggested a potential benefit with use of an EGFR tyrosine kinase inhibitor in the adjuvant setting in patients with EGFR-mutated non-small cell lung cancer. These nonrandomized studies cannot substitute for well-conducted, adequately powered, prospectively randomized phas...
Na minha lista:
| Udgivet i: | Oncologist |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AlphaMed Press
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4571806/ https://ncbi.nlm.nih.gov/pubmed/26268739 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0182 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|